<SEC-DOCUMENT>0001213900-26-039986-index.html : 20260403
<SEC-HEADER>0001213900-26-039986.hdr.sgml : 20260403
<ACCEPTANCE-DATETIME>20260403163353
ACCESSION NUMBER:		0001213900-26-039986
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20260324
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260403
DATE AS OF CHANGE:		20260403

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Drugs Made In America Acquisition II Corp.
		CENTRAL INDEX KEY:			0002040475
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		ORGANIZATION NAME:           	05 Real Estate & Construction
		EIN:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42863
		FILM NUMBER:		26838602

	BUSINESS ADDRESS:	
		STREET 1:		1 EAST BROWARD BOULEVARD
		STREET 2:		SUITE 700
		CITY:			FORT LAUDERDALE
		STATE:			FL
		ZIP:			33301
		BUSINESS PHONE:		954-870-3104

	MAIL ADDRESS:	
		STREET 1:		1 EAST BROWARD BOULEVARD
		STREET 2:		SUITE 700
		CITY:			FORT LAUDERDALE
		STATE:			FL
		ZIP:			33301
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea0285112-8k_drugs2.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
Document 1 - file: ea0285112-8k_drugs2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.1 <SEQUENCE>2 <FILENAME>ea028511201ex10-1.htm <DESCRIPTION>DEFINITIVE INVESTMENT AND SPONSOR TRANSITION AGREEMENT <TEXT> Document 2 - file: ea028511201ex10-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>ea028511201_ex10-1img1.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: ea028511201_ex10-1img1.jpg
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.SCH <SEQUENCE>4 <FILENAME>dmiiu-20260324.xsd <DESCRIPTION>XBRL SCHEMA FILE <TEXT> Document 4 - file: dmiiu-20260324.xsd
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.DEF <SEQUENCE>5 <FILENAME>dmiiu-20260324_def.xml <DESCRIPTION>XBRL DEFINITION FILE <TEXT> Document 5 - file: dmiiu-20260324_def.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.LAB <SEQUENCE>6 <FILENAME>dmiiu-20260324_lab.xml <DESCRIPTION>XBRL LABEL FILE <TEXT> Document 6 - file: dmiiu-20260324_lab.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.PRE <SEQUENCE>7 <FILENAME>dmiiu-20260324_pre.xml <DESCRIPTION>XBRL PRESENTATION FILE <TEXT> Document 7 - file: dmiiu-20260324_pre.xml
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>9 <FILENAME>R1.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 9 - file: R1.htm
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>10 <FILENAME>report.css <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 10 - file: report.css
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>11 <FILENAME>Show.js <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 11 - file: Show.js
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>13 <FILENAME>FilingSummary.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 13 - file: FilingSummary.html
Document 13 - RAW XML: FilingSummary.xml
</DOCUMENT> <DOCUMENT> <TYPE>JSON <SEQUENCE>15 <FILENAME>MetaLinks.json <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 15 - file: MetaLinks.json
</DOCUMENT> <DOCUMENT> <TYPE>ZIP <SEQUENCE>16 <FILENAME>0001213900-26-039986-xbrl.zip <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 16 - file: 0001213900-26-039986-xbrl.zip
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>17 <FILENAME>ea0285112-8k_drugs2_htm.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 17 - file: ea0285112-8k_drugs2_htm.html
Document 17 - RAW XML: ea0285112-8k_drugs2_htm.xml
</DOCUMENT> </SEC-DOCUMENT>